New COVID-19 nasal spray outperforms current antibody treatments in mice
Pre-school children’s emotional eating partly shaped by innate food drive, research shows
13 April 2022Changing product offerings in shops and restaurants can lead to leaner, greener diets
13 April 2022New COVID-19 nasal spray outperforms current antibody treatments in mice
A new protein-based antiviral nasal spray developed by researchers at Northwestern University, University of Washington and Washington University at St. Louis is being advanced toward Phase I human clinical trials to treat COVID-19.
